These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2509267)

  • 1. Effect of enprostil on gastric emptying, intestinal transit time and post-prandial release of gastro-intestinal peptides.
    Nicholl CG; Carolan G; Sevelius H; Bloom SR
    Digestion; 1989; 43(1-2):47-55. PubMed ID: 2509267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of postprandial glucose, insulin, C-peptide, and glucose-dependent insulinotropic peptide (GIP) in man by oral administration of a prostaglandin analogue (enprostil).
    Schwartz KE; Zaro B; Reynolds J; Duffy J; Saito T; Hunt JS; Sevelius H
    Horm Metab Res; 1988 Oct; 20(10):637-40. PubMed ID: 3146539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A synthetic prostaglandin E2 analogue, enprostil, hastens gastric emptying of solids in patients with an active duodenal ulcer.
    Nowak A; Jonderko K; Nowakowska-Duława E; Adamczak D; Rudzka J; Nowak S
    Scand J Gastroenterol; 1990 Nov; 25(11):1118-22. PubMed ID: 2125742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of four orally administered analogues of prostaglandin E1 and E2 on glucose tolerance and on the secretion of pancreatic and gastrointestinal hormones in man.
    Nauck M; Härter S; Ebert R; Creutzfeldt W
    Eur J Clin Invest; 1989 Jun; 19(3):298-305. PubMed ID: 2509214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of alimentary lipemia in man by a prostaglandin analogue (enprostil).
    Schwartz KE; Saito T
    Atherosclerosis; 1989 Oct; 79(2-3):231-6. PubMed ID: 2512938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of enprostil on glucose and lipid metabolism in type 2 diabetes.
    Davis TM; Proby C; Strong JA; Thompson GR; Massey H; Scott R; Bloom SR
    Diabet Med; 1989 Jul; 6(5):400-5. PubMed ID: 2527675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a long-acting somatostatin analogue (SMS 201-995) on postprandial gastric emptying of 99mTc-tin colloid and mouth-to-caecum transit time in man.
    Fuessl HS; Carolan G; Williams G; Bloom SR
    Digestion; 1987; 36(2):101-7. PubMed ID: 2883059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the Natural Sweetener Xylitol on Gut Hormone Secretion and Gastric Emptying in Humans: A Pilot Dose-Ranging Study.
    Meyer-Gerspach AC; Drewe J; Verbeure W; Roux CWL; Dellatorre-Teixeira L; Rehfeld JF; Holst JJ; Hartmann B; Tack J; Peterli R; Beglinger C; Wölnerhanssen BK
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33429977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric inhibitory polypeptide does not inhibit gastric emptying in humans.
    Meier JJ; Goetze O; Anstipp J; Hagemann D; Holst JJ; Schmidt WE; Gallwitz B; Nauck MA
    Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E621-5. PubMed ID: 14678954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of protective effect of oral enprostil, a synthetic prostaglandin E2, on intestinal transport and morphology following abdominal irradiation in the rat.
    Thomson AB; Keelan M; Clandinin MT; Tavernini M; Lam T; Walker K; Cheeseman CI
    Can J Physiol Pharmacol; 1989 Oct; 67(10):1351-6. PubMed ID: 2514980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a single oral dose of enprostil on gastric secretion and gastrin release. Studies in healthy volunteers and patients with pernicious anemia.
    Buchanan N; Laferla G; Hearns J; Buchanan KD; Crean GP; McColl KE
    Am J Med; 1986 Aug; 81(2A):40-3. PubMed ID: 3092653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of graded intraduodenal glucose infusions on the release and physiological action of gastric inhibitory polypeptide.
    McCullough AJ; Miller LJ; Service FJ; Go VL
    J Clin Endocrinol Metab; 1983 Feb; 56(2):234-41. PubMed ID: 6337173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a new oral somatostatin analog (SDZ CO 611) on gastric emptying, mouth to cecum transit time, and pancreatic and gut hormone release in normal male subjects.
    Nelson-Piercy C; Hammond PJ; Gwilliam ME; Khandan-Nia N; Myers MJ; Ghatei MA; Bloom SR
    J Clin Endocrinol Metab; 1994 Feb; 78(2):329-36. PubMed ID: 7906279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of glucose-dependent insulinotropic polypeptide on gastric emptying, glycaemia and insulinaemia during critical illness: a prospective, double blind, randomised, crossover study.
    Kar P; Cousins CE; Annink CE; Jones KL; Chapman MJ; Meier JJ; Nauck MA; Horowitz M; Deane AM
    Crit Care; 2015 Jan; 19(1):20. PubMed ID: 25613747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enprostil inhibits post-prandial gastrin release: a dose-response study.
    Lanzon-Miller S; Allison MC; Pounder RE; Ball S; Hamilton MR; Chronos NA
    Aliment Pharmacol Ther; 1988 Aug; 2(4):317-23. PubMed ID: 2979254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of enprostil on basal and meal-stimulated gastric acid and pepsin secretion, serum gastrin and gastric emptying in healthy persons.
    Berstad K; Massey H; Berstad A
    Aliment Pharmacol Ther; 1988 Feb; 2(1):65-72. PubMed ID: 2979235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of enprostil on plasma glucose, insulin and lipid metabolism in patients with non-insulin-dependent diabetes mellitus.
    Reaven GM; Swislocki AL; Jeng CY; Hollenbeck CB; Schwartz K; Chen YD
    Horm Metab Res; 1988 Oct; 20(10):633-6. PubMed ID: 3146538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of sitagliptin on gastric emptying in healthy humans - a randomised, controlled study.
    Stevens JE; Horowitz M; Deacon CF; Nauck M; Rayner CK; Jones KL
    Aliment Pharmacol Ther; 2012 Aug; 36(4):379-90. PubMed ID: 22738299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orlistat accelerates gastric emptying and attenuates GIP release in healthy subjects.
    Enç FY; Ones T; Akin HL; Dede F; Turoğlu HT; Ulfer G; Bekiroğlu N; Haklar G; Rehfeld JF; Holst JJ; Ulusoy NB; Imeryüz N
    Am J Physiol Gastrointest Liver Physiol; 2009 Mar; 296(3):G482-9. PubMed ID: 19109408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does intravenous ondansetron affect gastric emptying of a solid meal, gastric electrical activity or blood hormone levels in healthy volunteers?
    Netzer P; Gaia C; Lourens ST; Reber P; Wildi S; Noelpp U; Ritter EP; Ledermann H; Lüscher D; Varga L; Kinser JA; Büchler MW; Scheurer U
    Aliment Pharmacol Ther; 2002 Jan; 16(1):119-27. PubMed ID: 11856086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.